2080 related articles for article (PubMed ID: 19641173)
21. Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis.
Penny S; Khaleeli Z; Cipolotti L; Thompson A; Ron M
Neurology; 2010 Feb; 74(7):545-52. PubMed ID: 20157157
[TBL] [Abstract][Full Text] [Related]
22. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
Brochet B; Deloire MS; Bonnet M; Salort-Campana E; Ouallet JC; Petry KG; Dousset V
Mult Scler; 2008 Nov; 14(9):1242-9. PubMed ID: 18653737
[TBL] [Abstract][Full Text] [Related]
23. Cognitive impairment and structural brain damage in benign multiple sclerosis.
Rovaris M; Riccitelli G; Judica E; Possa F; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Mattioli F; Martinelli V; Comi G; Filippi M
Neurology; 2008 Nov; 71(19):1521-6. PubMed ID: 18815387
[TBL] [Abstract][Full Text] [Related]
24. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
[TBL] [Abstract][Full Text] [Related]
25. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
26. The cognitive burden of multiple sclerosis in children.
Banwell BL; Anderson PE
Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431
[TBL] [Abstract][Full Text] [Related]
27. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes.
Zipoli V; Goretti B; Hakiki B; Siracusa G; Sorbi S; Portaccio E; Amato MP
Mult Scler; 2010 Jan; 16(1):62-7. PubMed ID: 19995837
[TBL] [Abstract][Full Text] [Related]
28. Gray matter damage predicts the accumulation of disability 13 years later in MS.
Filippi M; Preziosa P; Copetti M; Riccitelli G; Horsfield MA; Martinelli V; Comi G; Rocca MA
Neurology; 2013 Nov; 81(20):1759-67. PubMed ID: 24122185
[TBL] [Abstract][Full Text] [Related]
29. Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients.
Río J; Rovira A; Tintoré M; Huerga E; Nos C; Tellez N; Tur C; Comabella M; Montalban X
Mult Scler; 2008 May; 14(4):479-84. PubMed ID: 18562504
[TBL] [Abstract][Full Text] [Related]
30. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
[TBL] [Abstract][Full Text] [Related]
31. Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients.
Minneboo A; Uitdehaag BM; Ader HJ; Barkhof F; Polman CH; Castelijns JA
Neurology; 2005 Jul; 65(1):56-61. PubMed ID: 16009885
[TBL] [Abstract][Full Text] [Related]
32. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.
Minneboo A; Barkhof F; Polman CH; Uitdehaag BM; Knol DL; Castelijns JA
Arch Neurol; 2004 Feb; 61(2):217-21. PubMed ID: 14967769
[TBL] [Abstract][Full Text] [Related]
33. Investigation of quantitative magnetisation transfer parameters of lesions and normal appearing white matter in multiple sclerosis.
Cercignani M; Basile B; Spanò B; Comanducci G; Fasano F; Caltagirone C; Nocentini U; Bozzali M
NMR Biomed; 2009 Jul; 22(6):646-53. PubMed ID: 19322806
[TBL] [Abstract][Full Text] [Related]
34. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years.
Rovaris M; Judica E; Gallo A; Benedetti B; Sormani MP; Caputo D; Ghezzi A; Montanari E; Bertolotto A; Mancardi G; Bergamaschi R; Martinelli V; Comi G; Filippi M
Brain; 2006 Oct; 129(Pt 10):2628-34. PubMed ID: 16921179
[TBL] [Abstract][Full Text] [Related]
35. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
36. May there exist specific MRI findings predictive of dementia in multiple sclerosis patients?
Patti F; Di Stefano M; De Pascalis D; Ciancio MR; De Bernardis E; Nicoletti F; Reggio A
Funct Neurol; 1995; 10(2):83-90. PubMed ID: 7557556
[TBL] [Abstract][Full Text] [Related]
37. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
[TBL] [Abstract][Full Text] [Related]
38. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.
Benedict RH; Weinstock-Guttman B; Fishman I; Sharma J; Tjoa CW; Bakshi R
Arch Neurol; 2004 Feb; 61(2):226-30. PubMed ID: 14967771
[TBL] [Abstract][Full Text] [Related]
39. MRI correlates of cognitive dysfunction in multiple sclerosis patients.
Rovaris M; Filippi M
J Neurovirol; 2000 May; 6 Suppl 2():S172-5. PubMed ID: 10871808
[TBL] [Abstract][Full Text] [Related]
40. Thalamic atrophy and cognition in multiple sclerosis.
Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
